Comparative Pharmacology
Head-to-head clinical analysis: READYPREP CHG versus SEPTI SOFT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: READYPREP CHG versus SEPTI SOFT.
READYPREP CHG vs SEPTI-SOFT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death. Its cationic nature binds to negatively charged bacterial cell walls, providing persistent antimicrobial activity.
Topical antiseptic; disrupts microbial cell membranes and denatures proteins via chlorhexidine gluconate and benzalkonium chloride.
No standard systemic dosing; used as a 4% chlorhexidine gluconate topical antiseptic solution applied once daily to entire body for preoperative skin preparation or for chlorhexidine bathing in infection prevention protocols.
Adults: 500 mg orally every 8 hours or 1 g orally every 12 hours.
None Documented
None Documented
60 minutes (terminal) in patients with normal renal function; prolonged in renal impairment.
Terminal elimination half-life: 8-12 hours (prolonged to 20-30 hours in renal impairment, requiring dose adjustment).
Renal: ~100% unchanged via glomerular filtration. No biliary or fecal elimination.
Renal (70-80% unchanged) via glomerular filtration and tubular secretion; biliary/fecal (15-20%) as metabolites.
Category C
Category C
Antiseptic
Antiseptic